[PDF] Progress In Drug Therapy For Children eBook

Author : Institute of Medicine
Publisher : National Academies Press
Page : 432 pages
File Size : 25,37 MB
Release : 2012-10-13
Category : Medical
ISBN : 0309225493

GET BOOK

The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.

Author : National Research Council
Publisher : National Academies Press
Page : 56 pages
File Size : 44,77 MB
Release : 2005-05-01
Category : Medical
ISBN : 0309096081

GET BOOK

The successes that have been achieved in treating childhood cancers stand as beacons against the less dramatic improvements for adults with cancer. Progress began to accelerate in the 1960s and 1970s, as treatment regimens were built up, primarily by building combinations of chemotherapeutic drugs. However the near absence of research in pediatric cancer drug discovery threatens to halt the progress in childhood cancer treatment achieved during the past four decades. Making Better Drugs for Children with Cancer identifies the major issues to be addressed in developing new agents for childhood cancers, the gaps in research and development, and the steps that have been suggested to move the process forward. This report also makes a new proposal to capitalize on today's science to bring new treatments to children's cancers.

Author : Karen A Theesen
Publisher : CRC Press
Page : 324 pages
File Size : 19,91 MB
Release : 1995-11-02
Category : Medical
ISBN :

GET BOOK

Presents current information on the safety and efficacy of psychotropic agents for use with pediatric patients, designed for use in a clinical setting. Sections on CNS stimulants, antidepressants, antipsychotics, lithium, benzodiazepines, and other agents provide information on products, pharmacokinetics, dosages, adverse effects, and monitoring gu.

Author : Xiaoming Li
Publisher : Elsevier Health Sciences
Page : 209 pages
File Size : 38,91 MB
Release : 2022-08-12
Category : Medical
ISBN : 0323987184

GET BOOK

In this issue of Pediatric Clinics of North America, guest editors Drs. Xiaoming Li and Sayward Harrison bring their considerable expertise to the topic of Progress in Behavioral Health Interventions for Children and Adolescents. Nearly three-quarters of adult mental health disorders have their onset during childhood, where treatment becomes more difficult and has greater social, educational, and economic consequences over time. This issue provides the information and resources needed to identify and treat mental health and clinical issues in children, with the goal of improving outcomes. Contains 16 relevant, practice-oriented topics including leveraging technology in novel interventions for autism spectrum disorder; childhood obesity prevention and treatment; parental rules, parental routines, and children’s (0-12 years) sleep and screen time; family-based preventions and interventions for child emotional and behavioral functioning in families facing stress/trauma; integrating behavioral health in primary care; and more. Provides in-depth clinical reviews on behavioral health interventions for children and adolescents, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.